600196 复星医药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资28,521,5358.15%26,371,62524,691,50123,919,39923,144,771
投资性房地产0--0000
固定资产18,198,6801.23%17,977,27117,385,19515,129,37110,267,859
在建工程2,973,332-2.69%3,055,4313,435,4514,938,2814,896,697
无形资产14,425,7083.05%13,999,15414,468,39313,482,01612,471,057
商誉10,709,070-0.93%10,809,75710,905,08310,851,99910,337,053
其他非流动资产15,800,23012.70%14,020,05912,083,88411,355,96910,767,292
90,628,5555.10%86,233,29882,969,50779,677,03671,884,729

流动资产
货币资金13,618,6483.93%13,104,22913,523,93313,693,59116,241,313
应收账款9,639,8622.94%9,364,5227,952,0737,643,7367,588,099
存货5,969,033-4.53%6,252,4727,258,6497,537,7686,882,432
其他流动资产5,571,8049.26%5,099,4485,756,4064,917,4744,567,333
34,799,3482.89%33,820,67134,491,06133,792,56935,279,178

流动负债
短期借款16,154,0484.02%15,529,94018,711,31514,728,45411,931,537
应付票据428,19848.70%287,969619,015652,252857,879
应付帐款4,596,560-5.34%4,856,0455,378,3705,507,3665,426,162
其他流动负债17,417,12210.58%15,750,36212,743,96912,869,51115,082,491
38,595,9275.96%36,424,31637,452,66933,757,58433,298,069
流动资产净值(3,796,579)45.82%(2,603,645)(2,961,609)34,9851,981,109
资产总额减流动负债86,831,9773.83%83,629,65380,007,89879,712,02173,865,838

非流动负债
长期借款11,016,8246.32%10,361,99110,203,50013,504,92311,600,437
应付债券2,000,00033.33%1,500,000240,0000499,431
其他非流动负债10,413,2304.89%9,927,3129,630,6699,590,8387,657,060
23,430,0547.53%21,789,30320,074,16923,095,76119,756,928

总权益
    实收股本2,670,4290.00%2,670,4292,671,3262,672,3992,672,157
    储备项目46,060,764-0.02%46,071,07844,589,78043,012,36341,910,301
股东权益48,731,193-0.02%48,741,50747,261,10745,684,76244,582,458
非控股权益14,670,72912.00%13,098,84312,672,62210,931,4999,526,452